Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;21(1):25-26.
doi: 10.1016/S1474-4422(21)00419-1.

Idiopathic hypersomnia: does first to approval mean first-line treatment?

Lynn Marie Trotti  1
Affiliations
Comment

Idiopathic hypersomnia: does first to approval mean first-line treatment?

Lynn Marie Trotti. Lancet Neurol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

LMT is a member of the Board of Directors of the American Academy of Sleep Medicine (AASM). All opinions expressed are those of LMT and do not necessarily reflect those of the AASM.

Comment on

Similar articles

See all similar articles

References

    1. Maski K, Trotti LM, Kotagal S, et al. Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline Journal of Clinical Sleep Medicine 2021; epub ahead of print. - PMC - PubMed
    1. FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment. published 8/12/21. https://www.fda.gov/news-events/press-announcements/fda-grants-first-its... (accessed 11/3/21.
    1. Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, et al. Efficacy and Safety of Lower-Sodium Oxybate in Adults With Idiopathic Hypersomnia: A Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study. Lancet Neurol 2022. - PubMed
    1. Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time-a randomized, double-blind, placebo-controlled study. J Sleep Res 2015; 24(1): 74–81. - PubMed
    1. Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Med 2021; 80: 315–21. - PubMed

LinkOut - more resources